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Summary Renal cell carcinoma (RCC) accounts for 2% of all human cancer, but familial cases are
infrequent. Riches (1963) and Griffin et al. (1967) found only 1% of cases were familial in their respective
series. McLaughlin et al. (1984) in a population-based case-control study found a family history of renal cell
carcinoma in 2.4% of affected patients compared to 1.4% of controls. Nevertheless the importance of
inherited tumours in clinical practice and medical research is disproportionate to their frequency. In clinical
practice recognition of familial RCC can provide opportunities to prevent morbidity and mortality by
appropriate screening. In medical research recent advances in molecular genetics offer the prospect of isolating
the genes involved in the pathogenesis of familial RCC and of the more common sporadic cases. In this article
we review the clinical and molecular genetics of inherited renal cell carcinoma (adenocarcinoma or hyperneph-
roma).
Clinical aspects
As with other inherited tumours, familial RCC is charac-
terised by (i) an early age at onset compared to sporadic
cases, (ii) frequent bilaterality and (iii) multicentricity. Mean
age at diagnosis in familial cases is about 45 years, more than
15 years earlier than for sporadic cases (Maher et al., 1990a;
Erlandsson et al., 1988). Two main groups of inherited RCC
can be distinguished (i) those which occur as part of von
Hippel-Lindau (VHL) disease and (ii) those with 'pure'
inherited RCC and no additional features.
Von Hippel-Lindau disease
This is the most frequent cause of inherited RCC and sub-
clinical evidence of VHL disease should be sought in all cases
of inherited or multiple RCC. This autosomal dominant
cancer syndrome has a heterozygote prevalence of 1 in 50,000
persons and 700 patients have been reported (Lamiell et al.,
1989; Maher et al., 1990b). The characteristic manifestations
of VHL disease are retinal, cerebellar and spinal haemangio-
blastomas, RCC, phaeochromocytoma, and renal, pancreatic
and epididymal cysts. Infrequent complications include pan-
creatic tumours (APUDomas or carcinoma), supratentorial
haemangioblastoma and angiomas in the spleen, adrenal
glands or liver (Horton et al., 1976; Lamiell et al., 1989;
Maher et al., 1990b). Conventional diagnostic criteria require
that in the absence of a family history the diagnosis can be
made in the presence of two or more haemangioblastomas or
a single haemangioblastoma associated with a visceral lesion
(Melmon & Rosen, 1964). When there is a family history of
haemangioblastoma then only a single manifestation is neces-
sary to make the diagnosis. Most patients with VHL disease
present before age 40 years and almost all gene carriers can
be identified by age 60 if appropriate screening is performed
(Maher et al., 1990b). Although RCC is the presenting
feature in only 10% of patients with VHL disease the risk of
developing a RCC rises progressively from age 20 and is
70% by age 60 years (Maher et al., 1990b). Comprehensive
screening programmes have been proposed (Huson et al.,
1986; Jennings et al., 1988; Maher et al., 1990b; Lamiell et
al., 1989) and annual renal imaging (ultrasound or CT scan)
from age 20 years is mandatory for both affected patients
and at risk relatives. Multiple renal cysts are frequent in
VHL disease and have been found in up to 76% of patients
(Horton et al., 1976). These cysts may be precancerous and
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in patients with multiple renal cysts a continuum from simple
benign cysts to frank RCC may be seen (Solomon &
Schwartz 1988; Ibrahim et al., 1989). RCC in VHL disease
patients has been reported to be bilateral and multicentric in
up to 75% and 87% of patients respectively (Fill et al.,
1979).
Familial Renal Cell Carcinoma without additionalfeatures
The literature contains 23 reports of 105 patients with fam-
ilial RCC (Clemmesen, 1942; Rusche, 1953; Krumbach &
Ansell, 1959; Brinton, 1960; Riches, 1963; Griffin et al., 1967;
Klinger, 1968; Pearson, 1969; Horn & Horn, 1971; Steinberg
et al., 1972; Franksson et al., 1972; Guiguis, 1973; Valleteau
de Mouillac et al., 1974; Braun, 1975; Lyons et al., -1977;
Pilepich et al., 1978; Cohen et al., 1979; Goldman et al.,
1979; Reddy, 1981; Li et al., 1982; Pathak et al., 1982;
McLaughlin et al., 1984; Mathieson, 1986). The mean age at
diagnosis of patients with inherited RCC is 48 years (Erland-
sson et al., 1988) similar to the mean age at diagnosis of
RCC in VHL disease. The most likely mode of inheritance is
autosomal dominant with age-dependent penetrance, vertical
transmission being observed in 17 of 29 families available for
analysis. The kindred reported by Cohen et al. (1979) con-
tained ten affected patients in three generations, but here
there was an association between RCC and a balanced 3;8
translocation with breakpoints at 3pl4.2 and 8q24.1. RCC
was only seen in translocation carriers, each of whom had an
87% risk of developing RCC by 60 years of age. There are
no other reports of familial RCC being associated with con-
stitutional chromosome translocations but sporadic cases
associated with 3;12 and 3;6 translocations have been re-
ported (Kovacs & Hoene, 1988; Kovacs et al., 1989a). Not
all patients with familial RCC will have been karyotyped, but
Kantor et al. (1982) did not find any constitutional chromo-
some 3 rearrangements in seven patients with familial
tumours nor in five with bilateral disease or 23 with an early
age at onset.
The multiple atypical renal cysts seen in VHL disease do
not appear to be a prominent feature of other forms of
inherited RCC. The family reported by Franksson et al.
(1972) with RCC and polycystic kidneys may have had VHL
disease. Apart from multicentricity the histopathological
appearances of all forms of inherited RCC are similar to
those of non-familial tumours. Early detection of RCC im-
proves prognosis (Smith et al., 1989) and patients at risk for
familial RCC should be screened annually from age 20 as in
VHL disease (see above).
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Molecular genetics of inherited RCC
Although there is a rat model of dominantly inherited RCC
(Eker et al., 1981), most recent research interest has focused
on the molecular genetics of human inherited RCC and it is
now clear that genes on the short arm of chromosome 3 are
implicated in the pathogenesis of familial and non-familial
cases of nonpapillary RCC (Kovacs et al., 1989b). Statistical
analysis of the age-at-diagnosis of RCC in VHL disease and
other forms of familial RCC (Maher et al., 1990a; Erland-
sson et al., 1988) suggests a single stage mutation model of
tumourigenesis as in inherited retinoblastoma (Cavenee et al.,
1983). Reports of cytogenetic deletions and allele loss in
VHL disease tumours are compatible with the VHL gene
functioning as a recessive tumour suppressor gene (King et
al., 1987; Tory et al., 1989). The precise localisation of the
genes responsible for familial RCC is the subject of intense
interest. Genetic linkage studies in families with VHL disease
place the VHL locus at the tip of chromosome 3p (3p25-26)
(Seizinger et al., 1988; Maher et al., 1990c, 1990d). However
the breakpoint in the 3;8 translocation family reported by
Cohen et al. (1979) is more proximal at 3pl4.2 (Wang &
Perkins 1984) (Figure 1). Although the c-myc oncogene
situated at 8q24.1 is translocated, there is no evidence of any
rearrangement or alteration of c-myc expression (Drabkin et
al., 1989). Thus it has been presumed that the predisposition
for RCC in this family results from the disruption of a gene
(the 'first hit') at or close to the translocation breakpoint on
chromosome 3p (Drabkin et al., 1989). Further support for
this hypothesis is provided by Kovacs et al. (1989b), who
described a patient with multiple bilateral RCC and a con-
stitutional 3;6 translocation (breakpoint between 3pl3 and
3pl4), and Pathak et al. (1982) who reported a patient with
familial RCC and normal constitutional karyotype, but a
chromosome 3;1 1 translocation (breakpoint at 3pl3 or 3pl4)
in tumour cells perhaps suggesting an inherited instability in
this region. Kovacs and Hoene (1988) have reported a non-
familial RCC in a patient with a constitutional 3;12 trans-
location with a breakpoint at 3ql3.2 in whom the derivative
chromosome containing 3p was lost from the tumour cells. In
this case it may be that the translocation prediposes to RCC
because of a tendency for the derivative chromosome to be
lost when the 'first hit' has occurred on the normal chromo-
some. Alternatively the translocation may be more complex
than it appears with involvement of the short arm of chromo-
some 3 as well as the long arm. Further molecular genetic
studies of tumours associated with constitutional chromo-
some 3 rearrangements would be of interest.
Statistical analyses of the age at onset of non-familial RCC
are compatible with a two stage mutation model of tumouri-
genesis as in retinoblastoma and Wilms' tumour (Maher et
al., 1990a; Erlandsson et al., 1988; Knudson 1971; Knudson
& Strong, 1972). In retinoblastoma non-familial tumours
result from mutations at the same locus as familial tumours.
For Wilms' tumour multiple loci exist: there are two loci on
chromosome 11 (llpl3 and 1lpl 5) at which acquired muta-
tions in both familial and non-familial tumours may occur.
The locus for the inherited predisposition to Wilms' tumour
has not yet been mapped but has been excluded from the
short arm of chromosome 11 (Jeanpierre et al., 1990; Grundy
et al., 1988).
Cytogenetic and molecular studies of sporadic RCC have
consistently demonstrated chromosome 3p rearrangements
(Zbar et al., 1987; Yoshida et al., 1986; Bergerheim et al.,
1989; Kovacs et al., 1988). Furthermore, Shimizu et al.
(1990) recently reported that the introduction of a normal
chromosome 3p modulated the tumourigenicity of a human
renal cell carcinoma cell line. In molecular genetic studies of
sporadic RCC the most frequent change is allele loss from
chromosome 3p2l-1 pter (Zbar et al., 1987; Kovacs et al.,
1988; Bergerheim et al., 1989). This includes the region to
which the VHL disease gene has been localised (3p25-26)
but the region of the 3;8 translocation breakpoint (3pl4) is
not always involved (Figure 1). However Teyssier et al.
(1986) have described two sporadic RCC with an interstitial
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Figure 1 Indeogram of chromosome 3 showing (i) the region of
the VHL disease locus (3p25-p26), (ii) location of the break-
points in the 3;8 translocation family reported by Cohen et al.
(1979) and the 3;6 translocation described by Kovacs et al.
(1989b) (3p13-pl4), (iii) the breakpoint in the 3;12 translocation
reported by Kovacs and Hoene (1988) (3ql3.2).
deletion of chromosome 3p which spared the region of the
VHL disease gene. This suggests that at least two loci on
chromosome 3p are involved in the pathogenesis of non-
familial RCC. One locus is situated distally and may be the
VHL disease gene itself, another is more proximal (3pl3-21)
and may be the site of the translocation breakpoints at
3pl-3pl4. RCC seems to be similar to Wilms' tumour in
that multiple loci are involved.
Human oncogenesis is a multistep process and activation
of H-ras oncogenes and chromosome lIp allele loss have
both been reported in human RCC (Fujita et al., 1988;
Anglard et al., 1989). Nevertheless, the primary role of
gene(s) on chromosome 3p in the pathogenesis of RCC is
suggested by the observation that the introduction of a nor-
mal chromosome 11 into a human RCC cell line had no
effect on tumourigenicity or cell growth (Shimizu et al.,
1990). Several other human cancers are associated with
chromosome 3p allele loss including small and non-small
lung cell carcinoma, uterine and breast cancer. Recently,
Naylor et al. (1989) and Erlandsson et al. (1990) have
independently isolated the same gene from chromosome 3p21
and proposed it as a possible candidate gene for small cell
lung carcinoma and for RCC respectively. Further research
into the molecular pathology of inherited and sporadic RCC
will be needed to elucidate the number and localisation of the178 E.R. MAHER & J.R.W. YATES
genes involved in the pathogenesis of these tumours and their
possible relationship to those associated with other forms of
human cancer.
Conclusions
Patients with familial or multicentric RCC should be investi-
gated for subclinical evidence of VHL disease and for
chromosome 3 rearrangements. At risk relatives should be
identified and offered appropriate screening investigations.
Molecular genetic research offers the prospect of reliable
presymptomatic diagnosis for VHL disease being available in
the near future, and blood and tumour samples for DNA
analysis should be collected and stored from all affected
patients. As the risk of recurrent tumours is high all such
patients should receive lifelong follow-up.
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